{
    "2020-04-02": [
        [
            {
                "time": "",
                "original_text": "君正集团：大安制药经营状况无重大不利事项",
                "features": {
                    "keywords": [
                        "君正集团",
                        "大安制药",
                        "经营状况",
                        "重大不利事项"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "君正集团高溢价增资关联方  标的公司持续经营能力存疑  经营问题",
                "features": {
                    "keywords": [
                        "君正集团",
                        "高溢价",
                        "增资",
                        "关联方",
                        "持续经营能力",
                        "存疑",
                        "经营问题"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}